Welcome!

News Feed Item

AbbVie Announces New Art Gallery Designed To Provide Perspectives On The Impact Of Chronic Inflammatory Diseases

-- More than 200 artists inspired by patients in more than 40 countries

NORTH CHICAGO, Ill., Feb. 20, 2014 /PRNewswire/ -- AbbVie today announced the launch of 'Perspectives – Art, Inflammation and Me', an initiative designed to add a different dimension to the current understanding of immune-mediated inflammatory diseases (IMIDs) and their impact on patients and society.  More than 100 unique artistic expressions from the initiative are being debuted at the 9th Congress of the European Crohn's and Colitis Organisation (ECCO) in Copenhagen, Denmark from February 20th to 22nd.

(Photo: http://photos.prnewswire.com/prnh/20140220/CG67342-a)
(Photo: http://photos.prnewswire.com/prnh/20140220/CG67342-b)
(Photo: http://photos.prnewswire.com/prnh/20140220/CG67342-c)

"Art is a well-established medium to help educate," said Jose Miralles, Perspectives judge and professor, Facultad de Belles Arts de Valencia, Universitat Politecnica de Valencia, Spain. "The artistic expressions created through Perspectives vividly bring to life the stories, dreams and challenges of patients living with inflammatory diseases. We hope people can experience the gallery and learn something new about these conditions."

IMIDs are a group of progressive and potentially debilitating conditions that can affect various parts of the body such as the joints (rheumatoid arthritis), the bowels (Crohn's disease), the skin (psoriasis) and the spine (ankylosing spondylitis). IMIDs can have a serious and damaging impact on the day-to-day lives of those affected, and those around them[1].

More than 200 unique artistic expressions – all inspired by collaborations between artists and patients – provide new and different perspectives into some of the unknown, ignored or often underestimated burdens associated with some of these conditions. The initiative involves more than 200 artists from more than 40 countries around the world. In addition to professional and independent artists, Perspectives included art students from more than 15 universities in France, Canada, Italy and Spain through collaborations with the Polytechnic University of Valencia (Universitat Politecnica de Valencia).

The artistic expressions include but are not limited to sculptures, photographs, paintings and installations. Perspectives will visit various art galleries and medical conferences throughout the world, with additional exhibition dates and locations to be announced later this year.

"The stories and artworks in Perspectives may contribute to the current understanding of these diseases and their impact on patients and society from a very personal and emotional point of view," said Isidro Villanueva, M.D., Ph.D., group therapeutic area lead, Medical Affairs, Immunology, AbbVie. "AbbVie is a global, research-based biopharmaceutical company committed to addressing some of today's toughest health challenges. Helping others understand the impact associated with some of these chronic conditions is part of that commitment."  

About Perspectives
'Perspectives – Art, Inflammation and Me' is an initiative that brings together more than 200 artists with patients in more than 40 countries. Together, they have created a series of paintings, sculptures, photos and other artistic expressions that vividly depict — and help others understand — the impact of immune-mediated inflammatory diseases (IMIDs). Inspired by patients' stories, independent artists and students from a number of art universities created each piece to help more people better understand the burdens associated with some of these chronic and debilitating conditions. In addition to independent artists from all parts of the world, students from more than 15 universities coordinated by the Polytechnic University of Valencia (Universitat Politecnica de Valencia) were able to add their "Perspectives."  

Key Perspectives artworks featured at ECCO include:

'Tic Tac Toe'– A cross-stitching artwork from the U.S., symbolic of life with Crohn's Disease (CD). Much like a game, CD is a disease through which there are personal wins, losses and draws. Words like hope, strength, endurance, courage, ache and "ow" illustrate the range of emotions experienced while on the road from awareness to diagnosis – noting that while one does not always win at the game of life or CD, one still has to play.
Artist: Barbara Miller

'Coexistentia'– A sculpture from Spain that portrays the story of a patient with Crohn's disease. The body is made of iron, representing the emotional armour that the patient constructs to protect themselves from the impact of the disease, and the intestinal area is made of marble, a hard and compact material, to symbolize the disease itself.
Artist: Guillermo Ros Lluch

'Captive?' – A photograph taken at a historic jail in Ireland that signifies the patient's feeling of entrapment, both physically and emotionally, and his sense of being 'locked up'. Framed in the doorway of a cell, the patient is neither inside the cell nor out. As with his condition, ulcerative colitis, no barriers are immediately apparent but confinements are all around.
Artist: John Minihan

Note: Full-size, high resolution images of these artworks are available upon request.

About AbbVie
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories.  The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases.  AbbVie employs approximately 25,000 people worldwide and markets medicines in more than 170 countries.  For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com.  Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.

[1] Kuek A, Hazleman BL and Ostor AJK. Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgrad Med J 2007; 83(978): 251-260

SOURCE AbbVie

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that Interoute has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Interoute is the owner operator of Europe's largest network and a global cloud services platform, which encompasses over 70,000 km of lit fiber, 15 data centers, 17 virtual data centers and 33 colocation centers, with connections to 195 additional partner data centers. Our full-service Unifie...
Most DevOps journeys involve several phases of maturity. Research shows that the inflection point where organizations begin to see maximum value is when they implement tight integration deploying their code to their infrastructure. Success at this level is the last barrier to at-will deployment. Storage, for instance, is more capable than where we read and write data. In his session at @DevOpsSummit at 20th Cloud Expo, Josh Atwell, a Developer Advocate for NetApp, will discuss the role and value...
Cloud applications are seeing a deluge of requests to support the exploding advanced analytics market. “Open analytics” is the emerging strategy to deliver that data through an open data access layer, in the cloud, to be directly consumed by external analytics tools and popular programming languages. An increasing number of data engineers and data scientists use a variety of platforms and advanced analytics languages such as SAS, R, Python and Java, as well as frameworks such as Hadoop and Spark...
In order to meet the rapidly changing demands of today’s customers, companies are continually forced to redefine their business strategies in order to meet these needs, stay relevant and continue to see profitable growth. IoT deployment and development is integral in this transformation, and today businesses are increasingly seeing the value of investing their resources into IoT deployments. These technologies are able increase ROI through projects such as connecting supply chains or enabling sm...
IBM helps FinTechs and financial services companies build and monetize cognitive-enabled financial services apps quickly and at scale. Hosted on IBM Bluemix, IBM’s platform builds in customer insights, regulatory compliance analytics and security to help reduce development time and testing. In his session at 20th Cloud Expo, Tom Eck, Industry Platforms CTO at IBM Cloud, will discuss how these tools simplify the time-consuming tasks of selection, mapping and data integration, allowing developers ...
SYS-CON Events announced today that Progress, a global leader in application development, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Enterprises today are rapidly adopting the cloud, while continuing to retain business-critical/sensitive data inside the firewall. This is creating two separate data silos – one inside the firewall and the other outside the firewall. Cloud ISVs ofte...
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm.
SYS-CON Events announced today that DivvyCloud will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. DivvyCloud software enables organizations to achieve their cloud computing goals by simplifying and automating security, compliance and cost optimization of public and private cloud infrastructure. Using DivvyCloud, customers can leverage programmatic Bots to identify and remediate common cloud problems in rea...
Interested in leveling up on your Cloud Foundry skills? Join IBM for Cloud Foundry Days on June 7 at Cloud Expo New York at the Javits Center in New York City. Cloud Foundry Days is a free half day educational conference and networking event. Come find out why Cloud Foundry is the industry's fastest-growing and most adopted cloud application platform.
For financial firms, the cloud is going to increasingly become a crucial part of dealing with customers over the next five years and beyond, particularly with the growing use and acceptance of virtual currencies. There are new data storage paradigms on the horizon that will deliver secure solutions for storing and moving sensitive financial data around the world without touching terrestrial networks. In his session at 20th Cloud Expo, Cliff Beek, President of Cloud Constellation Corporation, w...
While some vendors scramble to create and sell you a fancy solution for monitoring your spanking new Amazon Lambdas, hear how you can do it on the cheap using just built-in Java APIs yourself. By exploiting a little-known fact that Lambdas aren’t exactly single threaded, you can effectively identify hot spots in your serverless code. In his session at 20th Cloud Expo, David Martin, Principal Product Owner at CA Technologies, will give a live demonstration and code walkthrough, showing how to ov...
You know you need the cloud, but you’re hesitant to simply dump everything at Amazon since you know that not all workloads are suitable for cloud. You know that you want the kind of ease of use and scalability that you get with public cloud, but your applications are architected in a way that makes the public cloud a non-starter. You’re looking at private cloud solutions based on hyperconverged infrastructure, but you’re concerned with the limits inherent in those technologies.
SYS-CON Events announced today that Outscale, a global pure play Infrastructure as a Service provider and strategic partner of Dassault Systèmes, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Founded in 2010, Outscale simplifies infrastructure complexities and boosts the business agility of its customers. Outscale delivers a secure, reliable and industrial strength solution for its customers, which in...
As DevOps methodologies expand their reach across the enterprise, organizations face the daunting challenge of adapting related cloud strategies to ensure optimal alignment, from managing complexity to ensuring proper governance. How can culture, automation, legacy apps and even budget be reexamined to enable this ongoing shift within the modern software factory?
SYS-CON Events announced today that Cloudistics, an on-premises cloud computing company, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Cloudistics delivers a complete public cloud experience with composable on-premises infrastructures to medium and large enterprises. Its software-defined technology natively converges network, storage, compute, virtualization, and management into a ...